Geron Corp (GERN)

[jeffqdhsr]

The recent patent / patent applications IMO speak volumes for the future of the small Co !

The treatments indications for cancers are expanding as well, Since Geron has one J&J decision for one indication will they negotiate licensing for other treatments with other large pharma s & if so how much pressure does that put on J&J to decide, Its possible there are talks to expand licensing rights & that could be what is holding up J&J decision ? We know Imetelstat
studies are being conducted in "Combo" with other large Pharma, wonder how J&J is reacting to same. Those studies are in fact relevant to the overall usage and value of Imet

Any thought ?

All JMHO